Corrigendum to "Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer" [Eur J Cancer 53 (2016) 51-64].
Division of Gynecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Sandrina
S
Lambrechts
Laboratory for Translational Genetics, Vesalius Research Center, VIB, Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Dominiek
D
Smeets
Laboratory for Translational Genetics, Vesalius Research Center, VIB, Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Matthieu
M
Moisse
Department of Gynecology and Obstetrics, European Competence Center for Ovarian Cancer, Charité- University Medicine of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Elena Ioana
EI
Braicu
Division of Gynecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, KU Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Vesalius Research Center, VIB, Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Adriaan
A
Vanderstichele
Laboratory for Translational Genetics, Vesalius Research Center, VIB, Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Hui
H
Zhao
Division of Gynecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Els
E
Van Nieuwenhuysen
Erasmus MC, Cancer Institute, Department Medical Oncology, s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Els
E
Berns
Department of Gynecology and Obstetrics, European Competence Center for Ovarian Cancer, Charité- University Medicine of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Jalid
J
Sehouli
Department of Obstetrics and Gynecology, Molecular Oncology Group, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Robert
R
Zeillinger
Department of Gynecology and Obstetrics, European Competence Center for Ovarian Cancer, Charité- University Medicine of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Silvia
S
Darb-Esfahani
Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Gynecologic Cancer Unit, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Dan Cacsire
DC
Castillo-Tong
Laboratory for Translational Genetics, Vesalius Research Center, VIB, Leuven, Herestraat 49, 3000 Leuven, Belgium; Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: Diether.Lambrechts@vib-kuleuven.be.
Diether
D
Lambrechts
Division of Gynecological Oncology, Leuven Cancer Institute, Department of Gynaecology and Obstetrics, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
Ignace
I
Vergote